|
|
||||||||
J Thorac Cardiovasc Surg 1995;109:224-235
© 1995 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
Chapel Hill, N.C.
Address for reprints: Thomas M. Egan, MD, 108 Burnett-Womack Building, CB #7065, Chapel Hill, NC 27599-7065.
Abstract
Patients with cystic fibrosis pose particular challenges for lung transplantation surgeons. Earlier reports from North America centers suggested that patients with cystic fibrosis were greater risk for heart-lung or isolated lung transplantation than other patients with end-stage pulmonary disease. During a 3
year period, 44 patients with end-stage lung disease resulting from cystic fibrosis underwent double lung transplantation at this institution. During the same interval, 18 patients with cystic fibrosis, died while waiting for a double lung transplantation. The ages of the recipients ranged from 8 to 45 years, and mean forced expiratory volume in 1 second was 21% predicted. Seven patients had Pseudomonas cepacia bacteria before transplantation. Bilateral sequential implantation with omentopexy was used in all patients. There were no operative deaths, although two patients required urgent retransplantation because of graft failure. Cardiopulmonary bypass was necessary in six procedures in five patients and was associated with an increased blood transfusion requirement, longer postoperative ventilation, and longer hospital stay. Actuarial survival rate was 85% at 1 year and 67% at 2 years. Infection was the most common cause of death within 6 months of transplantation (Pseudomonas cepacia pneumonia was the cause of death in two patients), and bronchitis obliterans was the most common cause of death after 6 months. Actuarial freedom form development of clinically significant bronchiolitis obliterans was 59% at 2 years. Results of pulmonary function tests improved substantially in survivors, with forced expiratory volume in 1 second averaging 78% predicted 2 years after transplantation. Double lung transplantation can be accomplished with acceptable morbidity and mortality in patients with cystic fibrosis.(J THORACCARDIOVASSURG1995;109-:204-35)
This article has been cited by other articles:
![]() |
A. Y. Sheikh, M. P. Pelletier, and R. C. Robbins Heart-Lung and Lung Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1579 - 1608. [Full Text] |
||||
![]() |
D. Hadjiliadis Special Considerations for Patients With Cystic Fibrosis Undergoing Lung Transplantation Chest, April 1, 2007; 131(4): 1224 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ganesh, C. A. Rogers, R. S. Bonser, N. R. Banner, and on behalf of the steering group of the UK Cardioth Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study Eur. Respir. J., June 1, 2005; 25(6): 964 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, S. Quattrucci, E. A. Rendina, T. De Giacomo, E. Mercadante, M. Moretti, G. Cimino, and G. F. Coloni Improved results with lung transplantation for cystic fibrosis: a 6-year experience Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 21 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Balsam, D. D. Yuh, R. C. Robbins, and B. A. Reitz Heart-Lung and Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1461 - 1490. [Full Text] |
||||
![]() |
T.M. Egan, F.C. Detterbeck, M.R. Mill, M.S. Bleiweis, R. Aris, L. Paradowski, G. Retsch-Bogart, and B.S. Mueller Long term results of lung transplantation for cystic fibrosis Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 602 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Vricella, J. M. Karamichalis, S. Ahmad, R. C. Robbins, R. I. Whyte, and B. A. Reitz Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the stanford experience Ann. Thorac. Surg., July 1, 2002; 74(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, D. Huang, J. R. Hibbs, and B. C. Marshall Survival Effect of Lung Transplantation Among Patients With Cystic Fibrosis JAMA, December 5, 2001; 286(21): 2683 - 2689. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. CHAPARRO, J. MAURER, C. GUTIERREZ, M. KRAJDEN, C. CHAN, T. WINTON, S. KESHAVJEE, M. SCAVUZZO, E. TULLIS, M. HUTCHEON, et al. Infection with Burkholderia cepacia in Cystic Fibrosis . Outcome Following Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 43 - 48. [Abstract] [Full Text] |
||||
![]() |
C. D. VIZZA, R. D. YUSEN, J. P. LYNCH, F. FEDELE, G. ALEXANDER PATTERSON, and E. P. TRULOCK Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 819 - 825. [Abstract] [Full Text] |
||||
![]() |
C. W. Barlow, R. C. Robbins, M. R. Moon, O. Akindipe, J. Theodore, and B. A. Reitz HEART-LUNG VERSUS DOUBLE-LUNG TRANSPLANTATION FOR SUPPURATIVE LUNG DISEASE J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 466 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wiebe, Th. Wahlers, W. Harringer, H.v.d. Hardt, H. Fabel, and A. Haverich Lung transplantation for cystic fibrosis - a single center experience over 8 years Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Metras, L. Viard, B. Kreitmann, A. Riberi, A. Pannetier-Mille, O. Garbi, J.-Y. Marti, and P. Geigle Lung infections in pediatric lung transplantation: experience in 49 cases Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 490 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Doershuk and R. C. Stern Timing of Referral for Lung Transplantation for Cystic Fibrosis: Overemphasis on FEV1 May Adversely Affect Overall Survival Chest, March 1, 1999; 115(3): 782 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. HUSAIN, M. T. SIDDIQUI, E. W. HOLMES, A. J. CHANDRASEKHAR, M. MCCABE, R. RADVANY, and E. R. GARRITY Jr. Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 829 - 833. [Abstract] [Full Text] |
||||
![]() |
T. M. Egan, F. C. Detterbeck, M. R. Mill, K. K. Gott, J. B. Rea, J. McSweeney, R. M. Aris, and L. J. Paradowski Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group Ann. Thorac. Surg., August 1, 1998; 66(2): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Novick, L. W. Stitt, K. Al-Kattan, W. Klepetko, H.-J. Schafers, J.-P. Duchatelle, A. Khaghani, R. L. Hardesty, G. A. Patterson, and M. H. Yacoub Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients Ann. Thorac. Surg., January 1, 1998; 65(1): 227 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Novick, L. Stitt, H.-J. Schafers, B. Andreassian, J.-P. Duchatelle, W. Klepetko, R. L. Hardesty, A. Frost, and G. A. Patterson PULMONARY RETRANSPLANTATION: DOES THE INDICATION FOR OPERATION INFLUENCE POSTOPERATIVE LUNG FUNCTION? J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1504 - 1514. [Abstract] [Full Text] |
||||
![]() |
R. J. Novick, H.-J. Schafers, L. Stitt, B. Andreassian, W. Klepetko, R. L. Hardesty, A. Frost, and G. A. Patterson Seventy-two Pulmonary Retransplantations for Obliterative Bronchiolitis: Predictors of Survival Ann. Thorac. Surg., July 1, 1995; 60(1): 111 - 116. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |